133 related articles for article (PubMed ID: 12028564)
1. CD4+CD25+ T lymphocytes in human tonsils suppress the proliferation of CD4+CD25- tonsil cells.
Simark-Mattsson C; Dahlgren U; Roos K
Scand J Immunol; 2002 Jun; 55(6):606-11. PubMed ID: 12028564
[TBL] [Abstract][Full Text] [Related]
2. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.
Taams LS; Smith J; Rustin MH; Salmon M; Poulter LW; Akbar AN
Eur J Immunol; 2001 Apr; 31(4):1122-31. PubMed ID: 11298337
[TBL] [Abstract][Full Text] [Related]
3. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro.
Stephens LA; Mottet C; Mason D; Powrie F
Eur J Immunol; 2001 Apr; 31(4):1247-54. PubMed ID: 11298351
[TBL] [Abstract][Full Text] [Related]
4. The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells.
Zheng G; Wang B; Chen A
J Immunol; 2004 Aug; 173(4):2428-34. PubMed ID: 15294956
[TBL] [Abstract][Full Text] [Related]
5. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.
Ling EM; Smith T; Nguyen XD; Pridgeon C; Dallman M; Arbery J; Carr VA; Robinson DS
Lancet; 2004 Feb; 363(9409):608-15. PubMed ID: 14987885
[TBL] [Abstract][Full Text] [Related]
6. CD4+CD25high regulatory cells in human peripheral blood.
Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
[TBL] [Abstract][Full Text] [Related]
7. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.
Nakamura K; Kitani A; Strober W
J Exp Med; 2001 Sep; 194(5):629-44. PubMed ID: 11535631
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling of IL-2 signaling from cell cycle progression in naive CD4+ T cells by regulatory CD4+CD25+ T lymphocytes.
Duthoit CT; Mekala DJ; Alli RS; Geiger TL
J Immunol; 2005 Jan; 174(1):155-63. PubMed ID: 15611237
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function.
Brinster C; Shevach EM
J Immunol; 2005 Dec; 175(11):7332-40. PubMed ID: 16301639
[TBL] [Abstract][Full Text] [Related]
10. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
[TBL] [Abstract][Full Text] [Related]
11. Activated CD4+ CD25+ T cells suppress antigen-specific CD4+ and CD8+ T cells but induce a suppressive phenotype only in CD4+ T cells.
Dieckmann D; Plöttner H; Dotterweich S; Schuler G
Immunology; 2005 Jul; 115(3):305-14. PubMed ID: 15946248
[TBL] [Abstract][Full Text] [Related]
12. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.
Yamagiwa S; Gray JD; Hashimoto S; Horwitz DA
J Immunol; 2001 Jun; 166(12):7282-9. PubMed ID: 11390478
[TBL] [Abstract][Full Text] [Related]
13. Identification of a CD4+CD25+ T cell subset committed in vivo to suppress antigen-specific T cell responses without additional stimulation.
Nolte-'t Hoen EN; Wagenaar-Hilbers JP; Boot EP; Lin CH; Arkesteijn GJ; van Eden W; Taams LS; Wauben MH
Eur J Immunol; 2004 Nov; 34(11):3016-27. PubMed ID: 15376196
[TBL] [Abstract][Full Text] [Related]
14. Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance.
Palomares O; Rückert B; Jartti T; Kücüksezer UC; Puhakka T; Gomez E; Fahrner HB; Speiser A; Jung A; Kwok WW; Kalogjera L; Akdis M; Akdis CA
J Allergy Clin Immunol; 2012 Feb; 129(2):510-20, 520.e1-9. PubMed ID: 22051696
[TBL] [Abstract][Full Text] [Related]
15. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL
Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens.
Javia LR; Rosenberg SA
J Immunother; 2003; 26(1):85-93. PubMed ID: 12514432
[TBL] [Abstract][Full Text] [Related]
17. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.
Thornton AM; Shevach EM
J Exp Med; 1998 Jul; 188(2):287-96. PubMed ID: 9670041
[TBL] [Abstract][Full Text] [Related]
18. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.
Lindley S; Dayan CM; Bishop A; Roep BO; Peakman M; Tree TI
Diabetes; 2005 Jan; 54(1):92-9. PubMed ID: 15616015
[TBL] [Abstract][Full Text] [Related]
19. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid.
van Amelsfort JM; Jacobs KM; Bijlsma JW; Lafeber FP; Taams LS
Arthritis Rheum; 2004 Sep; 50(9):2775-85. PubMed ID: 15457445
[TBL] [Abstract][Full Text] [Related]
20. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.
Wang X; Zheng J; Liu J; Yao J; He Y; Li X; Yu J; Yang J; Liu Z; Huang S
Eur J Haematol; 2005 Dec; 75(6):468-76. PubMed ID: 16313258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
